G
GlucoTrack, Inc. (GCTK)
NCM – Real Time Price. Currency in USD
0.38
+0.00 (1.16%)
Market open: Aug 12, 2026, 12:40 PM EDT
0.38
+0.01 (2.29%)
Previous after-hours: Aug 11, 2026, 7:39 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.38
+0.00 (1.16%)
Market open: Aug 12, 2026, 12:40 PM EDT
0.38
+0.01 (2.29%)
Previous after-hours: Aug 11, 2026, 7:39 PM EDT
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
| Name | Position |
|---|---|
| Dr. Mark Tapsak Ph.D. | Chief Scientific Officer |
| Dr. Paul V. Goode Ph.D. | Chief Technical Officer, President & Director |
| Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus & Consultant |
| Mr. David Malka BA | Co-Founder |
| Mr. Erik C. Emerson | CEO & Director |
| Mr. Vincent Wong | Chief Operations Officer |
| Ms. Drinda Benjamin | Chief Commercial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-08-10 | DEF 14A | formdef14a.htm |
| 2026-08-05 | 8-K | form8-k.htm |
| 2026-07-31 | PRE 14A | formpre14a.htm |
| 2026-07-30 | 8-K | form8-k.htm |
| 2026-07-29 | 8-K/A | form8-ka.htm |
| 2026-07-27 | 8-K | form8-k.htm |
| 2026-07-17 | DEF 14A | formdef14a.htm |
| 2026-07-17 | ARS | formars.pdf |
| 2026-07-15 | 8-K | form8-k.htm |
| 2026-06-17 | PRE 14A | formpre14a.htm |